Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Characterization of Thyroid Cancer Driven by Known and Novel ALK Fusions.

Panebianco F, Nikitski AV, Nikiforova M, Kaya C, Yip L, Condello V, Wald AI, Nikiforov YE, Chiosea SI.

Endocr Relat Cancer. 2019 Sep 1. pii: ERC-19-0325.R1. doi: 10.1530/ERC-19-0325. [Epub ahead of print]

PMID:
31539879
2.

On challenges of disproving inferiority of tumor bed margins.

Kim S, Chiosea S.

Oral Dis. 2019 Jul 26. doi: 10.1111/odi.13165. [Epub ahead of print] No abstract available.

PMID:
31349395
3.

Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage.

Sridharan S, Thompson LDR, Purgina B, Sturgis CD, Shah AA, Burkey B, Tuluc M, Cognetti D, Xu B, Higgins K, Hernandez-Prera JC, Guerrero D, Bundele MM, Kim S, Duvvuri U, Ferris RL, Gooding WE, Chiosea SI.

Cancer. 2019 Sep 15;125(18):3198-3207. doi: 10.1002/cncr.32199. Epub 2019 Jun 7.

PMID:
31174238
4.

Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma.

Sebastiao APM, Pareja F, Kumar R, Brown DN, Silveira C, da Silva EM, Lee JY, Del A, Katabi N, Chiosea S, Weigelt B, Reis-Filho JS, Seethala RR.

Histopathology. 2019 Aug;75(2):193-201. doi: 10.1111/his.13854. Epub 2019 Jun 18.

PMID:
30843621
5.

Hamartoma of the Oral Cavity with Ectopic Meningothelial Elements in Infants: A Rare Entity with Report of Two Cases.

Tekkeşin MS, Chiosea SI, Ozolek JA.

Head Neck Pathol. 2019 Mar 6. doi: 10.1007/s12105-019-01024-2. [Epub ahead of print]

PMID:
30840224
6.

Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer.

Hedberg ML, Peyser ND, Bauman JE, Gooding WE, Li H, Bhola NE, Zhu TR, Zeng Y, Brand TM, Kim MO, Jordan RCK, VandenBerg S, Olivas V, Bivona TG, Chiosea SI, Wang L, Mills GB, Johnson JT, Duvvuri U, Ferris RL, Ha P, Johnson DE, Grandis JR.

J Exp Med. 2019 Feb 4;216(2):419-427. doi: 10.1084/jem.20181936. Epub 2019 Jan 25.

7.

GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.

Nikiforova MN, Nikitski AV, Panebianco F, Kaya C, Yip L, Williams M, Chiosea SI, Seethala RR, Roy S, Condello V, Santana-Santos L, Wald AI, Carty SE, Ferris RL, El-Naggar AK, Nikiforov YE.

Thyroid. 2019 Feb;29(2):161-173. doi: 10.1089/thy.2018.0791.

PMID:
30648929
8.

The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland.

Andreasen S, Varma S, Barasch N, Thompson LDR, Miettinen M, Rooper L, Stelow EB, Agander TK, Seethala RR, Chiosea SI, Homøe P, Wessel I, Larsen SR, Erentaite D, Bishop JA, Ulhøi BP, Kiss K, Melchior LC, Pollack JR, West RB.

Am J Surg Pathol. 2019 Apr;43(4):489-496. doi: 10.1097/PAS.0000000000001200.

PMID:
30520817
9.

Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.

Zhang L, Li Z, Liu Y, Xu S, Tandon M, Appelboom B, LaValle CR, Chiosea SI, Wang L, Sen M, Lui VWY, Grandis JR, Wang QJ.

BMC Cancer. 2018 Nov 12;18(1):1107. doi: 10.1186/s12885-018-4965-6.

10.

Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.

Steward DL, Carty SE, Sippel RS, Yang SP, Sosa JA, Sipos JA, Figge JJ, Mandel S, Haugen BR, Burman KD, Baloch ZW, Lloyd RV, Seethala RR, Gooding WE, Chiosea SI, Gomes-Lima C, Ferris RL, Folek JM, Khawaja RA, Kundra P, Loh KS, Marshall CB, Mayson S, McCoy KL, Nga ME, Ngiam KY, Nikiforova MN, Poehls JL, Ringel MD, Yang H, Yip L, Nikiforov YE.

JAMA Oncol. 2019 Feb 1;5(2):204-212. doi: 10.1001/jamaoncol.2018.4616. Erratum in: JAMA Oncol. 2019 Feb 1;5(2):271.

11.

Patients with revised surgical resection margins are best studied as a distinct group.

Sperry SM, Varvares MA, Chiosea SI.

Cancer. 2018 Nov 1;124(21):4262-4263. doi: 10.1002/cncr.31712. Epub 2018 Oct 9. No abstract available.

12.

Measuring Depth of Invasion in Early Squamous Cell Carcinoma of the Oral Tongue: Positive Deep Margin, Extratumoral Perineural Invasion, and Other Challenges.

Berdugo J, Thompson LDR, Purgina B, Sturgis CD, Tuluc M, Seethala R, Chiosea SI.

Head Neck Pathol. 2019 Jun;13(2):154-161. doi: 10.1007/s12105-018-0925-3. Epub 2018 Apr 26.

13.

Standardized Margin Assessment Is Needed Before Implementing Negative Margin as a Quality Measure.

Duvvuri U, Johnson JT, Chiosea SI.

JAMA Otolaryngol Head Neck Surg. 2018 Jun 1;144(6):541-542. doi: 10.1001/jamaoto.2018.0074. No abstract available.

PMID:
29596555
14.

Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland.

Weinreb I, Bishop JA, Chiosea SI, Seethala RR, Perez-Ordonez B, Zhang L, Sung YS, Chen CL, Assaad A, Oliai BR, Antonescu CR.

Am J Surg Pathol. 2018 Apr;42(4):442-452. doi: 10.1097/PAS.0000000000000952.

15.

Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.

El Hallani S, Udager AM, Bell D, Fonseca I, Thompson LDR, Assaad A, Agaimy A, Luvison AM, Miller C, Seethala RR, Chiosea S.

Am J Surg Pathol. 2018 Jan;42(1):18-27. doi: 10.1097/PAS.0000000000000933.

16.

Clear Cell Carcinoma of Salivary Glands Is Frequently p16 Positive: A Pitfall in the Interpretation of Oropharyngeal Biopsies.

Bishop JA, Rooper LM, Chiosea SI, Westra WH.

Am J Surg Pathol. 2018 Mar;42(3):367-371. doi: 10.1097/PAS.0000000000000977.

17.

Improving margin revision: Characterization of tumor bed margins in early oral tongue cancer.

Prabhu AV, Sturgis CD, Lai C, Maxwell JH, Merzianu M, Hernandez-Prera JC, Purgina B, Thompson LDR, Tuluc M, Yang X, Seethala RR, Ferris RL, Chiosea SI.

Oral Oncol. 2017 Dec;75:184-188. doi: 10.1016/j.oraloncology.2017.10.013. Epub 2017 Nov 1.

18.

Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.

Agaimy A, Michal M, Chiosea S, Petersson F, Hadravsky L, Kristiansen G, Horch RE, Schmolders J, Hartmann A, Haller F, Michal M.

Am J Surg Pathol. 2017 Oct;41(10):1371-1380. doi: 10.1097/PAS.0000000000000890.

PMID:
28614212
19.

Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.

Dogan S, Chute DJ, Xu B, Ptashkin RN, Chandramohan R, Casanova-Murphy J, Nafa K, Bishop JA, Chiosea SI, Stelow EB, Ganly I, Pfister DG, Katabi N, Ghossein RA, Berger MF.

J Pathol. 2017 Aug;242(4):400-408. doi: 10.1002/path.4915. Epub 2017 Jun 9.

20.

HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.

Mito JK, Jo VY, Chiosea SI, Dal Cin P, Krane JF.

Histopathology. 2017 Oct;71(4):511-521. doi: 10.1111/his.13246. Epub 2017 Jul 5.

PMID:
28463429
21.

Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.

Rath TJ, Narayanan S, Hughes MA, Ferris RL, Chiosea SI, Branstetter BF 4th.

AJNR Am J Neuroradiol. 2017 Jul;38(7):1405-1410. doi: 10.3174/ajnr.A5177. Epub 2017 Apr 27.

22.

Retracted: Worst Pattern Of Invasion and occult cervical metastases for oral squamous carcinoma.

Velosa C, Shi Q, Stevens TM, Chiosea SI, Purgina B, Carroll W, Rosenthal E, Morlandt A, Loree T, Brandwein-Weber MS.

Head Neck. 2017 Mar 28. doi: 10.1002/hed.24754. [Epub ahead of print]

PMID:
28370646
23.

Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.

Bauman JE, Duvvuri U, Gooding WE, Rath TJ, Gross ND, Song J, Jimeno A, Yarbrough WG, Johnson FM, Wang L, Chiosea S, Sen M, Kass J, Johnson JT, Ferris RL, Kim S, Hirsch FR, Ellison K, Flaherty JT, Mills GB, Grandis JR.

JCI Insight. 2017 Mar 23;2(6):e90449. doi: 10.1172/jci.insight.90449.

24.

Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.

Udager AM, Chiosea SI.

Head Neck Pathol. 2017 Sep;11(3):288-294. doi: 10.1007/s12105-017-0798-x. Epub 2017 Mar 20. Review.

25.

SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.

Agaimy A, Hartmann A, Antonescu CR, Chiosea SI, El-Mofty SK, Geddert H, Iro H, Lewis JS Jr, Märkl B, Mills SE, Riener MO, Robertson T, Sandison A, Semrau S, Simpson RH, Stelow E, Westra WH, Bishop JA.

Am J Surg Pathol. 2017 Apr;41(4):458-471. doi: 10.1097/PAS.0000000000000797.

26.

THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer.

Panebianco F, Kelly LM, Liu P, Zhong S, Dacic S, Wang X, Singhi AD, Dhir R, Chiosea SI, Kuan SF, Bhargava R, Dabbs D, Trivedi S, Gandhi M, Diaz R, Wald AI, Carty SE, Ferris RL, Lee AV, Nikiforova MN, Nikiforov YE.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2307-2312. doi: 10.1073/pnas.1614265114. Epub 2017 Feb 13.

27.

Intraoperative Margin Assessment in Early Oral Squamous Cell Carcinoma.

Chiosea SI.

Surg Pathol Clin. 2017 Mar;10(1):1-14. doi: 10.1016/j.path.2016.10.002. Epub 2016 Dec 10. Review.

PMID:
28153128
28.

Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure.

Seethala RR, Chiosea SI, Liu CZ, Nikiforova M, Nikiforov YE.

Am J Surg Pathol. 2017 Apr;41(4):446-457. doi: 10.1097/PAS.0000000000000814.

29.

Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations.

Li YY, Chung GT, Lui VW, To KF, Ma BB, Chow C, Woo JK, Yip KY, Seo J, Hui EP, Mak MK, Rusan M, Chau NG, Or YY, Law MH, Law PP, Liu ZW, Ngan HL, Hau PM, Verhoeft KR, Poon PH, Yoo SK, Shin JY, Lee SD, Lun SW, Jia L, Chan AW, Chan JY, Lai PB, Fung CY, Hung ST, Wang L, Chang AM, Chiosea SI, Hedberg ML, Tsao SW, van Hasselt AC, Chan AT, Grandis JR, Hammerman PS, Lo KW.

Nat Commun. 2017 Jan 18;8:14121. doi: 10.1038/ncomms14121.

30.

Reappraising hyalinizing clear cell carcinoma: A population-based study with molecular confirmation.

Hernandez-Prera JC, Kwan R, Tripodi J, Chiosea S, Cordon-Cardo C, Najfeld V, Demicco EG.

Head Neck. 2017 Mar;39(3):503-511. doi: 10.1002/hed.24637. Epub 2016 Nov 29.

PMID:
27898192
31.

Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein-Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines.

Chang AMV, Chiosea SI, Altman A, Pagdanganan HA, Ma C.

Head Neck Pathol. 2017 Jun;11(2):203-211. doi: 10.1007/s12105-016-0765-y. Epub 2016 Nov 2.

32.

Does a specimen-based margin analysis of early tongue cancer better predict local control?

Varvares MA, Walker RJ, Chiosea S.

Laryngoscope. 2016 Nov;126(11):2426-2427. doi: 10.1002/lary.26081. Epub 2016 Jun 16. Review. No abstract available.

PMID:
27313090
33.

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Thyroid Carcinoma.

Chiosea S, Asa SL, Berman MA, Carty SE, Currence L, Hodak S, Nikiforov YE, Richardson MS, Seethala RR, Sholl LM, Thompson LD, Wenig BM, Worden F; Members of the Cancer Biomarker Reporting Committee, College of American Pathologists.

Arch Pathol Lab Med. 2017 Apr;141(4):559-563. doi: 10.5858/arpa.2016-0326-CP. Epub 2016 Sep 28. No abstract available.

PMID:
27681332
34.

Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.

Chiosea SI, Thompson LD, Weinreb I, Bauman JE, Mahaffey AM, Miller C, Ferris RL, Gooding WE.

Cancer. 2016 Oct 15;122(20):3136-3144. doi: 10.1002/cncr.30179. Epub 2016 Jul 5.

35.

MAML2 Status in Mucoepidermoid Carcinoma Can No Longer Be Considered a Prognostic Marker.

Seethala RR, Chiosea SI.

Am J Surg Pathol. 2016 Aug;40(8):1151-3. doi: 10.1097/PAS.0000000000000676. No abstract available.

PMID:
27299797
36.

Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer.

Argiris A, Bauman JE, Ohr J, Gooding WE, Heron DE, Duvvuri U, Kubicek GJ, Posluszny DM, Vassilakopoulou M, Kim S, Grandis JR, Johnson JT, Gibson MK, Clump DA, Flaherty JT, Chiosea SI, Branstetter B, Ferris RL.

Ann Oncol. 2016 Aug;27(8):1594-600. doi: 10.1093/annonc/mdw204. Epub 2016 May 13.

37.

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.

Hedberg ML, Goh G, Chiosea SI, Bauman JE, Freilino ML, Zeng Y, Wang L, Diergaarde BB, Gooding WE, Lui VW, Herbst RS, Lifton RP, Grandis JR.

J Clin Invest. 2016 Apr 1;126(4):1606. doi: 10.1172/JCI86862. Epub 2016 Apr 1. No abstract available.

38.

The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.

Ledgerwood LG, Kumar D, Eterovic AK, Wick J, Chen K, Zhao H, Tazi L, Manna P, Kerley S, Joshi R, Wang L, Chiosea SI, Garnett JD, Tsue TT, Chien J, Mills GB, Grandis JR, Thomas SM.

Oncotarget. 2016 May 10;7(19):27185-98. doi: 10.18632/oncotarget.8448.

39.

Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules.

Karunamurthy A, Panebianco F, J Hsiao S, Vorhauer J, Nikiforova MN, Chiosea S, Nikiforov YE.

Endocr Relat Cancer. 2016 Apr;23(4):295-301. doi: 10.1530/ERC-16-0043. Epub 2016 Feb 24.

40.

Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.

Olevian DC, Nikiforova MN, Chiosea S, Sun W, Bahary N, Kuan SF, Pai RK.

Hum Pathol. 2016 Mar;49:124-34. doi: 10.1016/j.humpath.2015.11.004. Epub 2015 Nov 17.

PMID:
26826419
41.

Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.

Wasserman JK, Purgina B, Lai CK, Gravel D, Mahaffey A, Bell D, Chiosea SI.

Head Neck Pathol. 2016 Sep;10(3):279-85. doi: 10.1007/s12105-015-0678-1. Epub 2016 Jan 12.

42.

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.

Hedberg ML, Goh G, Chiosea SI, Bauman JE, Freilino ML, Zeng Y, Wang L, Diergaarde BB, Gooding WE, Lui VW, Herbst RS, Lifton RP, Grandis JR.

J Clin Invest. 2016 Jan;126(1):169-80. doi: 10.1172/JCI82066. Epub 2015 Nov 30. Erratum in: J Clin Invest. 2016 Apr 1;126(4):1606.

43.

TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.

Dixit R, Kemp C, Kulich S, Seethala R, Chiosea S, Ling S, Ha PK, Duvvuri U.

Sci Rep. 2015 Nov 13;5:16657. doi: 10.1038/srep16657.

44.

Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.

Afkhami M, Karunamurthy A, Chiosea S, Nikiforova MN, Seethala R, Nikiforov YE, Coyne C.

Thyroid. 2016 Feb;26(2):242-7. doi: 10.1089/thy.2015.0227. Epub 2015 Dec 17.

PMID:
26422023
45.

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.

Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN.

Thyroid. 2015 Nov;25(11):1217-23. doi: 10.1089/thy.2015.0305. Epub 2015 Sep 10.

46.

Primary RET-mutated lung neuroendocrine carcinoma in MEN2B: response to RET-targeted therapy.

Geiger JL, Chiosea SI, Challinor SM, Nikiforova MN, Bauman JE.

Endocr Relat Cancer. 2015 Oct;22(5):L19-22. doi: 10.1530/ERC-15-0307. Epub 2015 Aug 18. No abstract available.

PMID:
26285607
47.

Clinicopathologic and Immunophenotypic Characterization of 25 Cases of Acinic Cell Carcinoma with High-Grade Transformation.

Thompson LD, Aslam MN, Stall JN, Udager AM, Chiosea S, McHugh JB.

Head Neck Pathol. 2016 Jun;10(2):152-60. doi: 10.1007/s12105-015-0645-x. Epub 2015 Aug 6.

48.

Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local Control.

Maxwell JH, Thompson LD, Brandwein-Gensler MS, Weiss BG, Canis M, Purgina B, Prabhu AV, Lai C, Shuai Y, Carroll WR, Morlandt A, Duvvuri U, Kim S, Johnson JT, Ferris RL, Seethala R, Chiosea SI.

JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1104-10. doi: 10.1001/jamaoto.2015.1351.

49.

Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.

Van Allen EM, Lui VW, Egloff AM, Goetz EM, Li H, Johnson JT, Duvvuri U, Bauman JE, Stransky N, Zeng Y, Gilbert BR, Pendleton KP, Wang L, Chiosea S, Sougnez C, Wagle N, Zhang F, Du Y, Close D, Johnston PA, McKenna A, Carter SL, Golub TR, Getz G, Mills GB, Garraway LA, Grandis JR.

JAMA Oncol. 2015 May;1(2):238-44. doi: 10.1001/jamaoncol.2015.34.

50.

Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.

Williams L, Thompson LD, Seethala RR, Weinreb I, Assaad AM, Tuluc M, Ud Din N, Purgina B, Lai C, Griffith CC, Chiosea SI.

Am J Surg Pathol. 2015 May;39(5):705-13. doi: 10.1097/PAS.0000000000000413.

PMID:
25871467

Supplemental Content

Loading ...
Support Center